Prosecution Insights
Last updated: October 08, 2026

Dewitt LLP (Madison)

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

79 pending office actions • 51 clients • 75 examiners • 47 art units • 0 of 79 (0%) have an AI response strategy ready

Analysis

DeWitt LLP (Madison) has a significant presence in Biotechnology & Pharmaceuticals, with 6252 career applications in its history. The firm maintains a resolved allowance rate of 82.15 percent, demonstrating a strong capability for securing patent rights. This success is achieved with an average of 2.92 office actions per allowance, indicating an efficient prosecution process.

The firm currently manages 58 pending office actions, showing its active involvement in the Biotechnology & Pharmaceuticals sector. The 82.15 percent allowance rate is a critical indicator of the firm's effectiveness in overcoming examiner rejections. With 6252 career applications, the firm demonstrates extensive experience in handling complex technical subject matter.

Practitioners can look to the 2.92 average office actions per allowance as a metric for planning prosecution strategy and budgeting. The 58 pending office actions indicate a steady flow of work within the firm's specialized area. These figures provide a clear overview of DeWitt LLP (Madison)'s performance and its established position in the patent landscape.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=6252 apps, methodology: how we score firms)

82.2%
Allowance Rate
n=6252
+0.55σ
Allowance Rate (norm)
n=6252
2.9
OAs to Allowance
n=4316
-0.36σ
OAs to Allow (norm)
n=4316
1064 days
Time to Allowance
n=4316
+13.2pp
Interview Lift
n=6252
18.6%
RCE Rate
n=6252
1.4%
Appeal Rate
n=6252

Rejection Performance (% of received rejections ultimately overcome)

78.5%
§101 Overcome
n=251
84.3%
§102 Overcome
n=1538
83.3%
§103 Overcome
n=2462
85.1%
§112 Overcome
n=1816

Specialization & Scale

Y10T, A61B, G06F
Top CPC Subclasses
10%
Top-3 CPC Share
n=6252
0
Practitioners
n=6252
—
Apps / Practitioner
n=6252 (min 20)

Portfolio Summary

79
Total Pending OAs
53
Non-Final OAs
25
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

8
Overdue
0
Due this week
3
Due this month
3
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (8)Due ≤ 30 days (3)Due ≤ 60 days (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

46
Hard (58%)
27
Medium (34%)
6
Easy (8%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other8 (10%)
§103 only18 (23%)
§102 only2 (3%)
§112 only6 (8%)
Double-patenting + other7 (9%)
Multi-statute (no §101)38 (48%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

26
Life Sciences
33% of docket
5
Information Tech
6% of docket
1
Communications
1% of docket
7
Semiconductors
9% of docket
18
Mechanical / Eng
23% of docket
22
Business / Other
28% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

790 h
Manual time on pending OAs
158 h
Time saved (low, 20%)
276 h
Time saved (mid, 35%)
6.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ARMSTRONG, SUSANNAH SIPPLE 3 30.0% +53.1%
HUTSON, RICHARD G 2 65.1% +52.9%
SMALE, AVERY E 2 73.8% +19.8%
CHAI, RAYMOND REI-YANG 1 74.8% +16.2%
HIBSHMAN, SARAH GRACE 1 38.9% +40.0%
COOK, JONATHON 1 81.6% +17.1%
JOHNSON, TERRELL S 1 86.8% +10.4%
BLOCH, MICHAEL RYAN 1 50.0% +54.6%
DIETRICH, JOSEPH M 1 81.1% +8.8%
HILTUNEN, THOMAS J 1 81.5% +6.1%

Hard Cases (46)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18842106 CARBON DIOXIDE CAPTURE AND UTILIZATION AS A CLEAN FEEDSTOCK WONG, EDNA 85d overdue
17912770 ATP-DEPENDENT DNA LIGASE HUTSON, RICHARD G 80d overdue
18533548 IMAGING SENSOR ASSEMBLY PHAM, QUAN L 8d overdue
18696845 MEASURING APPARATUS AND MEASURING METHOD FOR PREPARING LASER TREATMENT, AND LASER TREATMENT APPARATUS HO, WAI-GA DAVID 5d overdue
18637243 COMPOSITIONS TO CONTROL THE RELEASE RATES OF CHEMICAL PESTICIDES ARMSTRONG, SUSANNAH SIPPLE 1d overdue
18573804 FOOD IN CONTROLLED DYNAMIC FERMENTATION FOR BACTERIOSTASIS OF BENEFICIAL MICROORGANISMS, KEEPING THEM ALIVE AND METABOLICALLY ACTIVE FOR HUMAN CONSUMPTION MORENO, LARK JULIA 8d
18579119 CLOSURE CAP AND CLOSURE SYSTEM FOR A SYRINGE THAT IS PREFILLED WITH A MEDICAMENT OR MEDICAL ACTIVE SUBSTANCE BURKE, THOMAS P 23d
17190514 INTRAOCULAR IMPLANT AND METHOD FOR PRODUCING AN INTRAOCULAR IMPLANT MANNAN, MIKAIL A 34d

Interview Candidates (12)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17912770 ATP-DEPENDENT DNA LIGASE HUTSON, RICHARD G 80d overdue
18257613 PULSATILE FLUSHING OF MEDICAL DEVICES SMALE, AVERY E 46d overdue
19237691 FLAVONOID-CONTAINING COMPOSITIONS AND TREATMENT OF VIRAL DISEASES WITH SAME HIBSHMAN, SARAH GRACE 43d overdue
18637243 COMPOSITIONS TO CONTROL THE RELEASE RATES OF CHEMICAL PESTICIDES ARMSTRONG, SUSANNAH SIPPLE 1d overdue
18470587 ADMINISTRATION REGIMENS FOR MICRONEEDLE PATCH DEVICES FOR DELIVERY OF IMMUNOGENIC COMPOSITIONS SMALE, AVERY E 42d
19142798 ELECTRON TUBE CHAI, RAYMOND REI-YANG —
19197529 METHOD FOR COMPENSATING THE ARTIFACTS GENERATED BY MOVING MEASUREMENT OBJECTS IN MEASUREMENT SIGNALS OF SWEPT-SOURCE OCT SYSTEMS COOK, JONATHON —
19088105 CIRCUITRY AND METHODS FOR MITIGATING PROCESSING EVENTS JOHNSON, TERRELL S —

Client Portfolio (51 clients)

View all 51 →

Top Art Units

Art UnitApps
16163
37923
16232
21762
16542
28722
37832
16412
37742
28451

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19142798 ELECTRON TUBE Nisshinbo Micro Devices Inc. CHAI, RAYMOND REI-YANG 2845 §112 Non-Final OA — Pending Jun 24, 2025
19237691 FLAVONOID-CONTAINING COMPOSITIONS AND TREATMENT OF VIRAL DISEASES WITH SAME Amh Biotech LLC HIBSHMAN, SARAH GRACE 1623 §103 Non-Final OA 43d overdue Pending Jun 13, 2025
19197529 METHOD FOR COMPENSATING THE ARTIFACTS GENERATED BY MOVING MEASUREMENT OBJECTS IN MEASUREMENT SIGNALS OF SWEPT-SOURCE OCT SYSTEMS Carl Zeiss Meditec AG COOK, JONATHON §102§103§112 Non-Final OA — Pending May 02, 2025
19088105 CIRCUITRY AND METHODS FOR MITIGATING PROCESSING EVENTS Arm Limited JOHNSON, TERRELL S 2176 §102§103 Non-Final OA — Pending Mar 24, 2025
19107996 BIOLOGICAL SOUND DETECTION DEVICE Nisshinbo Micro Devices Inc. BLOCH, MICHAEL RYAN §102 Non-Final OA — Pending Feb 28, 2025
18698295 INTERMEDIATE STORAGE UNIT FOR CYCLICAL POWER SMOOTHING AND OPHTHALMOLOGICAL LASER THERAPY SYSTEM HAVING AN INTERMEDIATE STORAGE UNIT Carl Zeiss Meditec AG DIETRICH, JOSEPH M §102§103§112 Non-Final OA — Pending Feb 25, 2025
19041411 POWER MANAGEMENT SYSTEMS AND CIRCUITRY Arm Limited HILTUNEN, THOMAS J 2836 §102§103 Non-Final OA — Pending Jan 30, 2025
19032890 STORAGE META DATA INTERROGATION Arm Limited DUDEK JR, EDWARD J 2132 §103 Final Rejection — Pending Jan 21, 2025
18992537 PROTEASE ACTIVATED RECEPTOR 2 (PAR2) INHIBITOR AND ITS USES Università Degli Studi Di Padova WEBB, WALTER E §102§103DP Non-Final OA — Pending Jan 08, 2025
18880710 DELIMITED MACHINE-ENABLED LANGUAGE TRANSLATION Cabo Applications LLC PATEL, SHREYANS A §101§102§103 Non-Final OA — Pending Jan 02, 2025
18877373 TILLER Reecher Marine AB HESTON, JUSTIN MICHAEL 3644 §102§103 Non-Final OA — Pending Dec 20, 2024
18982318 POWER REGULATOR FOR DIGITAL CIRCUITRY Arm Limited CORDOVA RODRIGUEZ, ULARISLAO 2838 §102§103 Non-Final OA — Pending Dec 16, 2024
18980870 HEADGEAR MOUNT AND IMAGING SYSTEM Maranon, Inc. CROCKETT, RYAN M §103 Non-Final OA — Pending Dec 13, 2024
18971144 WATER FLOW DEFLECTION DEVICE FOR A WATERCRAFT AND METHODS OF USE Swell Ventures LLC VASUDEVA, AJAY §102§103§112Other Non-Final OA — Pending Dec 06, 2024
18970384 LASER INSTRUMENT FOR EYE THERAPY Carl Zeiss Meditec AG WILLIAMS, CATHERINE SERKE 3993 §103§112Other Non-Final OA — Pending Dec 05, 2024
18694856 METHOD AND ASSEMBLY FOR RECALIBRATING THE FOCUS OF AN OPHTHALMOLOGICAL SYSTEM FOR INTRAOCULAR LASER TREATMENT Carl Zeiss Meditec AG OKONAK, ELIZABETH LOUISE §101§103§112 Non-Final OA — Pending Nov 18, 2024
18939932 STORAGE CIRCUITRY FOR READ AND WRITE OPERATIONS Arm Limited NGUYEN, KATHY KIEU NGOC 2825 §103§112 Non-Final OA — Pending Nov 07, 2024
18925406 DROOP PROTECTION METHOD AND CIRCUIT Arm Limited KIM, JUNG H §102§103 Final Rejection — Pending Oct 24, 2024
18926235 EVALUATING PERFORMANCE OF A DROOP MITIGATION SCHEME Arm Limited BIRKHIMER, CHRISTOPHER D 2138 §102§103§112 Final Rejection — Pending Oct 24, 2024
18925518 METHOD OF MONITORING A CLOCK SIGNAL Arm Limited REHMAN, MOHAMMED H 2176 §103 Final Rejection — Pending Oct 24, 2024
18889634 LARGE-SCALE STONE SLABS Cambria Company LLC WEYDEMEYER, ETHAN 1744 §102§103§112 Non-Final OA — Pending Sep 19, 2024
18843473 FUNGICIDE COMPOSITION UPL Corporation Limited GEMBEH, SHIRLEY V §112DP Final Rejection — Pending Sep 03, 2024
18842176 CRANIAL FIXATION DEVICE FOR DECOMPRESSIVE / AUGMENTATIVE CRANIECTOMY Ntplast S.r.l. WEISBERG, AMY REGINA §102§103§112Other Non-Final OA — Pending Aug 28, 2024
18842106 CARBON DIOXIDE CAPTURE AND UTILIZATION AS A CLEAN FEEDSTOCK Michigan Technological University WONG, EDNA 1795 §103§112 Final Rejection 85d overdue Pending Aug 28, 2024
18808704 MODULAR EDGE NETWORK SECURITY Adveon Security Technologies, Inc. TRUONG, LAWRENCE QUANG 2434 §103 Final Rejection — Pending Aug 19, 2024
18835471 FUNGICIDE COMPOSITION UPL Corporation Limited SONG, JIANFENG §103DP Final Rejection — Pending Aug 02, 2024
18832605 METHOD OF IMPROVING PLANT GROWTH UPL Corporation Limited ARMSTRONG, SUSANNAH SIPPLE 1616 §101§102§103§112Other Final Rejection — Pending Jul 24, 2024
18832577 METHOD OF CONTROLLING FUNGI UPL Corporation Limited ABBAS, ABDULRAHMAN MUSTAFA §102§103§112DP Non-Final OA — Pending Jul 24, 2024
18770925 LIQUID DALBAVANCIN COMPOSITIONS Hikma Pharmaceuticals Usa Inc. D' AMBROSIO, THEA 1654 §103§112DP Non-Final OA — Pending Jul 12, 2024
18725699 THERAPEUTICAL PEPTIDOMIMETIC Association Française Contre Les Myopathies – Afm-Téléthon HUTSON, RICHARD G §102§112 Non-Final OA — Pending Jun 28, 2024
18720062 EXTENDABLE UNIVERSAL SOUND BAR MOUNT Legrand Av Inc. TAN, DING Y 3632 §112 Final Rejection — Pending Jun 14, 2024
18717505 ORAL FORMULATION BASED ON A PRE-ESTABLISHED ASSOCIATION OF SULODEXIDE AND FLAVONOIDS FOR THE TREATMENT OF CHRONIC VENOUS INSUFFICIENCY AND PREVENTION OF COMPLICATIONS THEREOF Omikron Italia S.r.l. MCINTOSH III, TRAVISS C 1623 §101§103 Non-Final OA — Pending Jun 07, 2024
18733464 GOSERELIN IMPLANT DOSING REGIMENS FOR IMPROVED PATIENT COMPLIANCE Tersera Therapeutics LLC JOHNSON, TIRONE DEREK §103§112 Non-Final OA — Pending Jun 04, 2024
18715978 SIMULTANEOUS REMOVAL OF CARBON DIOXIDE, NOx and SOx USING SINGLE STAGE ABSORPTION COLUMN AND RELATED METHODS Michigan Technological University LEE, CRYSTAL J §103§112 Non-Final OA — Pending Jun 03, 2024
18637243 COMPOSITIONS TO CONTROL THE RELEASE RATES OF CHEMICAL PESTICIDES Envionics LLC ARMSTRONG, SUSANNAH SIPPLE 1616 §103§112Other Non-Final OA 1d overdue Pending Apr 16, 2024
18637035 CONTROL FOR FLOOR SCRAPING MACHINE National Flooring Equipment, Inc. FLORES SANCHEZ, OMAR 3724 §102 Non-Final OA — Pending Apr 16, 2024
18635772 DEVICES AND METHODS FOR LASER SURGERY OF AN EYE, ESPECIALLY FOR KERATOPLASTY Resbiomed Technologies Ood HODGE, LAURA NICOLE 3792 §103 Final Rejection — Pending Apr 15, 2024
18634477 LIFT FRAME ASSEMBLY Hiab AB NEUPANE, ADARSH 3652 §103 Non-Final OA — Pending Apr 12, 2024
18699742 WELDING MACHINE AND METHOD FOR PRODUCING A BUTT-WELDED JOINT Huerner Schweisstechnik GmbH TOLIN, MICHAEL A 1745 §102§103§112 Non-Final OA — Pending Apr 09, 2024
18698824 PLANNING DEVICE FOR GENERATING CONTROL DATA FOR A LASER DEVICE OF A TREATMENT APPARATUS FOR REFRACTIVE CORRECTION OF AN EYE, TREATMENT APPARATUS, METHOD FOR GENERATING CONTROL DATA AND METHOD FOR REFRACTIVE CORRECTION Carl Zeiss Meditec AG SCHMITT, BENJAMIN ALLYN 3796 §101§103§112 Final Rejection — Pending Apr 05, 2024
18696845 MEASURING APPARATUS AND MEASURING METHOD FOR PREPARING LASER TREATMENT, AND LASER TREATMENT APPARATUS Carl Zeiss Meditec AG HO, WAI-GA DAVID 2872 §103§112 Final Rejection 5d overdue Pending Mar 28, 2024
18693777 TIMED SYSTEM FOR RAPID ASSAY Cubit Diagnostics, Inc. BORTOLI, JONATHAN §103§112 Non-Final OA — Pending Mar 20, 2024
18598827 COMPOSITIONS COMPRISING METAL-COMPLEXED PLANT COMPOUNDS AND USES THEREOF Rd Life Sciences, LLC FIEBIG, RUSSELL G 1655 §103§112 Non-Final OA — Pending Mar 07, 2024
18682242 VALVE Imperial College Innovations Ltd. LEDERER, SARAH B §102§103 Non-Final OA — Pending Feb 08, 2024
18435747 CONICAL STENT FOR INTRACRANIAL ANGIOPLASTY AND METHODS OF STENT PLACEMENT FOR PREVENTION AND TREATMENT OF ISCHEMIC STROKE Dyqure LLC PELLEGRINO, BRIAN E 3799 §103 Non-Final OA — Pending Feb 07, 2024
18427359 Recycled Graphite for Li-Ion Batteries Ascend Elements, Inc. BOWMAN, ANDREW J 1717 §102§103 Non-Final OA — Pending Jan 30, 2024
18579119 CLOSURE CAP AND CLOSURE SYSTEM FOR A SYRINGE THAT IS PREFILLED WITH A MEDICAMENT OR MEDICAL ACTIVE SUBSTANCE Inductio AG BURKE, THOMAS P 3741 §103§112 Final Rejection 23d Pending Jan 12, 2024
18573676 ENERGY PRODUCTION SYSTEM Photoncycle AS LEE, JAMES §103§112 Non-Final OA — Pending Dec 22, 2023
18573804 FOOD IN CONTROLLED DYNAMIC FERMENTATION FOR BACTERIOSTASIS OF BENEFICIAL MICROORGANISMS, KEEPING THEM ALIVE AND METABOLICALLY ACTIVE FOR HUMAN CONSUMPTION Kuragobiotek Holdings Sapi De Cv MORENO, LARK JULIA 1793 §103§112 Final Rejection 8d Pending Dec 22, 2023
18394354 METHOD OF PRODUCING CARBON MATERIALS FROM FEEDSTOCK GASES Up Catalyst Oü MENDEZ, ZULMARIAM §103§112 Non-Final OA — Pending Dec 22, 2023

View all 79 →

Managing Dewitt LLP (Madison)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Dewitt LLP (Madison)'s patent allowance rate?

82.2% of resolved applications prosecuted by Dewitt LLP (Madison) were allowed, across 6,252 applications in USPTO records.

How many office actions does Dewitt LLP (Madison) average before allowance?

2.92 office actions per allowed application on average.

How many pending office actions does Dewitt LLP (Madison) have?

79 pending office actions as of October 2026, for 51 clients, before 75 examiners in 47 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month